Mentionkit Publishes SourcetoMCP Case Study on Social Listening for B2B SaaS ERYTECH to Participate in Upcoming Virtual Investor Conferences in March
ERYTECH to Participate in Upcoming Virtual Investor Conferences in March Lyon (France) and Cambridge, MA…
Selecta Biosciences Announces Science Advances Publication Highlighting Potential Potency and Durability Benefits of ImmTOR™ in Gene Therapy
– Data demonstrate that ImmTOR has the potential to enhance transgene expression in the liver…
CytomX Therapeutics Announces Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
-Broad advancement of clinical pipeline- -Three-arm Phase 2 study of praluzatamab ravtansine (CX-2009) launched in…
10x Genomics Showcases Next Wave of Innovations at First Ever Xperience Event
Acquires Tetramer Shop; Reveals Details on Upcoming Products PLEASANTON, Calif., Feb. 24, 2021 (GLOBE NEWSWIRE)…
GBT Reports Recent Business Progress and Fourth Quarter and Full Year 2020 Financial Results
Achieved Oxbryta® (voxelotor) net revenues of $41.3 million in the fourth quarter and $123.8 million for…
Alimera Sciences Reports Fourth Quarter and 2020 Results
Fourth Quarter Highlights: Consolidated Net Revenue of $13.8 Million Up 10% vs. Third Quarter of…
Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2020 Financial Results
SEATTLE, Feb. 24, 2021 (GLOBE NEWSWIRE) — Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a…
Seer to Present at the Cowen 41st Annual Healthcare Conference
REDWOOD CITY, Calif., Feb. 24, 2021 (GLOBE NEWSWIRE) — Seer, Inc., (Nasdaq: SEER), a life…
Quotient Limited to Participate in the Cowen 41st Annual Healthcare Conference
JERSEY, Channel Islands, Feb. 24, 2021 (GLOBE NEWSWIRE) — Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics…
G1 Therapeutics Provides Fourth Quarter and Full Year 2020 Financial Results and Operational Highlights
– G1’s COSELA™ (trilaciclib) Approved by FDA as First and Only Therapy to Decrease the…
Paratek Pharmaceuticals Announces Full Year 2020 Total Revenue of $46.9 Million including NUZYRA® (omadacycline) Net U.S. Sales of $38.8 Million
— NUZYRA Generated Net U.S. Sales of $12.4 Million in the Fourth Quarter 2020; a…
InflaRx Announces Proposed Offering of Common Shares and One-Year Warrants
JENA, Germany, Feb. 24, 2021 (GLOBE NEWSWIRE) — InflaRx N.V. (Nasdaq: IFRX), a clinical-stage biopharmaceutical…
Vaxart to Provide 2021 Business Outlook on Tuesday, March 2, 2021
SOUTH SAN FRANCISCO, Calif., Feb. 24, 2021 (GLOBE NEWSWIRE) — Vaxart, Inc., a clinical-stage biotechnology…
BridgeBio Pharma To Announce Proof-Of-Concept Data from ADH1 at the Endocrine Society’s 2021 Annual Meeting
Company to Host Webcast to Discuss Proof-of-Concept Data for Encaleret in Autosomal Dominant Hypocalcemia Type…
Coherus BioSciences Reports Fourth Quarter and Full Year 2020 Financial Results
– Product revenues of $476 million for full year 2020, $110 million for the fourth…
Inventiva to participate at several investor conferences in March 2021
Daix (France), February 24, 2021 – Inventiva (Euronext Paris and Nasdaq: IVA), a clinical-stage biopharmaceutical…
Segra Enters Agreement Making BioAgronomics Group’s Premium Cannabis Cultivar Portfolio Available to Licensed Producers Across Canada and Select International Markets
VANCOUVER, British Columbia, Feb. 24, 2021 (GLOBE NEWSWIRE) — Segra International Corp., an AgTech firm…
LIDDS files patent application for method to treat brain cancer with intratumoral depot injections
UPPSALA, SWEDEN – LIDDS AB (publ) announced today that a patent application related to NanoZolid®…
Pan-Biome Pharmaceuticals, Inc reports positive results in preclinical trial of Inflammatory Bowel Disease: oral drug shows strong effect in modulating the gut microbiome
VANCOUVER, British Columbia, Feb. 24, 2021 (GLOBE NEWSWIRE) — Pan-Biome Pharmaceuticals, Inc, a Vancouver based…
22nd Century Group Provides Business Update Letter from CEO
Global Commercial Opportunities in Approximately +$800 Billion Markets Across Tobacco and Hemp/Cannabis WILLIAMSVILLE, N.Y., Feb….